Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study

BACKGROUND: Leptomeningeal metastasis (LM) is a severe complication of advanced non-small cell lung cancer (NSCLC). This retrospective study aimed to investigate the potential use of osimertinib for preventing LM in patients with advanced epidermal growth factor receptor (EGFR)-mutated NSCLC. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xia, Cai, Jing, Zeng, Zhimin, Liu, Anwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325312/
https://www.ncbi.nlm.nih.gov/pubmed/34330231
http://dx.doi.org/10.1186/s12885-021-08581-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325312/
https://www.ncbi.nlm.nih.gov/pubmed/34330231
http://dx.doi.org/10.1186/s12885-021-08581-2

Ejemplares similares